Sanara MedTech
Rapidly growing provider of first-in-class specialty medical products and advanced biotechnology.
Launch date
Employees
Market cap
$303m
Enterprise valuation
$313m (Public information from Sep 2024)
Share price
$33.3 SMTI
Addison Illinois (HQ)
Financials
Estimates*
| USD | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | 11.8m | 15.6m | 24.1m | 45.8m | 65.0m | 80.9m | 96.2m |
| % growth | 102 % | 32 % | 55 % | 90 % | 42 % | 24 % | 19 % |
| EBITDA | (2.5m) | (4.7m) | (7.4m) | (10.2m) | (4.0m) | - | - |
| % EBITDA margin | (21 %) | (30 %) | (31 %) | (22 %) | (6 %) | - | - |
| Profit | (2.8m) | (4.4m) | (7.9m) | (7.9m) | (4.3m) | - | - |
| % profit margin | (24 %) | (28 %) | (33 %) | (17 %) | (7 %) | - | - |
| R&D budget | - | <1m | <1m | 3.4m | 4.1m | - | - |
| R&D % of revenue | - | - | 2 % | 7 % | 6 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
N/A | Acquisition | ||
* | N/A | $15.0m | Post IPO Debt |
| Total Funding | - | ||
